Urinary tract effects of HPSE2 mutations. - Wikidata - awgldk - TriplyDB

Urinary tract effects of HPSE2 mutations.

Urinary tract effects of HPSE2 mutations.

http://www.wikidata.org/entity/Q35228493

about

From gene discovery to new biological mechanisms: heparanases and congenital urinary bladder disease Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth.Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage.Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression.

P2860

Q26796508-2617C309-BB63-4ECD-8B93-4D5CF1BD18BB Q36917969-5372A528-F908-443D-A091-09E2AE0B3AB6 Q37225598-F8734875-75C6-465A-9C1D-C71341609105 Q47377873-178CF8B3-2473-43B3-AF8B-43A923B7C5A4

P2860

Urinary tract effects of HPSE2 mutations.

http://www.wikidata.org/entity/Q35228493

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Urinary tract effects of HPSE2 mutations.

@ast

Urinary tract effects of HPSE2 mutations.

@en

type

label

Urinary tract effects of HPSE2 mutations.

@ast

Urinary tract effects of HPSE2 mutations.

@en

prefLabel

Urinary tract effects of HPSE2 mutations.

@ast

Urinary tract effects of HPSE2 mutations.

@en

P1433

Q35228493-55272AEE-0A0D-4FA2-85DA-DA048ACAAD43

P1476

Q35228493-A85B4030-DA33-473C-B833-49B5304AD2FD

P2093

Q35228493-05B0805D-D67F-415D-808D-CCCBD4B0504F

Q35228493-08B3A1F8-7903-44DC-9B77-E75419D5F57C

Q35228493-20E12260-167E-4C49-B238-F9FD0CCBA733

Q35228493-2882854E-C1C2-4360-B799-F8D215F9F32A

Q35228493-29AB1F7B-F9BE-4329-9478-127C0708710C

Q35228493-2A5CEAEA-99E8-4FAC-ABE6-962E4BC5509E

Q35228493-387D5B5E-98BA-43CE-B3EF-AE14B643E818

Q35228493-3A4BD109-E64A-4D29-95BF-F350CA51EFED

Q35228493-3B827CEE-4618-46A6-8F84-51EA4FEFC36D

Q35228493-3C40EB60-CAF7-4840-99F2-36D34138BC45

P2860

Q35228493-0CA43501-51A2-4CDA-9CAD-4600B73C2526

Q35228493-111E3DC3-0A20-466B-AD87-F21C9F3155FC

Q35228493-316BC87F-0760-4FA4-85E8-8FBEEE4F7643

Q35228493-35C9708A-1C84-407C-83A7-06E0B0CF055B

Q35228493-36C0D37A-93FC-45DD-A809-7A9BA7B0F11F

Q35228493-3AC5E2BA-D173-478B-9CE9-9BE59A9ACEE4

Q35228493-45F88AD4-5200-411D-98A5-0989EE8F00C5

Q35228493-4F9AE302-13E9-4B49-B476-3B44AB1AC572

Q35228493-59668C26-BA62-4E16-ABCE-5A5851B4AC4F

Q35228493-5D4F3C91-6936-42C4-8399-1275FC4CA782

P304

Q35228493-50426C45-4FDD-427F-AA2A-1C8C123CE91F

P31

Q35228493-24E9541A-AF87-418D-8CCE-E27DAF486F3A

P356

Q35228493-AE64E1F7-1D83-4055-8822-7924FD6A3F77

P433

Q35228493-7C1DE164-8F1F-4824-98D2-5BD6B55246E4

P478

Q35228493-47E806D0-72C2-41EE-ACD6-784493CF991D

P50

Q35228493-0CA7909C-EDDF-4E41-AE30-022D1A5EC4D3

Q35228493-0D136FAA-E866-4DB5-A162-6B2B9850FD4B

Q35228493-595627C1-84A7-43AE-88FA-5A6CBEA74B61

Q35228493-8AF1CD2B-FDEF-4FA9-A660-27AD8A637102

Q35228493-9EC4069E-34F8-46E9-900C-799925379AD6

Q35228493-AFE87857-9135-42EB-B3F4-33058331943D

Q35228493-C275E87F-FA32-434D-B9BA-D86EE6794BD0

Q35228493-EBAC46A4-EAD1-4362-8163-1CBBA3C0B76F

P577

Q35228493-0E220C71-E338-4CD3-9FDB-BF159BA62CEE

P698

Q35228493-33312F86-F967-466B-9872-62A51BBA6D06

P932

Q35228493-802EC785-7F9C-454C-A527-72743B9B6984

P356

P1433

Journal of the American Society of Nephrology

P1476

Urinary tract effects of HPSE2 mutations.

@en

P2093

4C Study Group

http://www.w3.org/2001/XMLSchema#string

Anand Saggar

http://www.w3.org/2001/XMLSchema#string

Angelina Calado

http://www.w3.org/2001/XMLSchema#string

Aysun K Bayazit

http://www.w3.org/2001/XMLSchema#string

Brad Angle

http://www.w3.org/2001/XMLSchema#string

Christian Lorenz

http://www.w3.org/2001/XMLSchema#string

Cláudia Alves

http://www.w3.org/2001/XMLSchema#string

David E Barton

http://www.w3.org/2001/XMLSchema#string

Edward A McKenzie

http://www.w3.org/2001/XMLSchema#string

Emily Sites

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member

Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity

Mutations in HPSE2 cause urofacial syndrome

LRIG2 mutations cause urofacial syndrome

Lrig2-deficient mice are protected against PDGFB-induced glioma

Ablation of mouse phosphomannose isomerase (Mpi) causes mannose 6-phosphate accumulation, toxicity, and embryonic lethality

Loss-of-function mutations in HPSE2 cause the autosomal recessive urofacial syndrome

A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract

Whole-genome linkage and association scan in primary, nonsyndromic vesicoureteric reflux

Exome capture and massively parallel sequencing identifies a novel HPSE2 mutation in a Saudi Arabian child with Ochoa (urofacial) syndrome.

P304

797-804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2013090961

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

William G. Newman

Adrian S. Woolf

Natalie J Gardiner

Heather Lambert

Christian Beetz

Helen M. Stuart

P577

2014-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25145936

http://www.w3.org/2001/XMLSchema#string

P932

4378092

http://www.w3.org/2001/XMLSchema#string